ЛІНОЗИД

उत्पाद अवलोकन

About ЛІНОЗИД

ЛІНОЗИД is an antibiotic medication used to treat various bacterial infections. It belongs to the class of oxazolidinone antibiotics and contains the active ingredient Linezolid. This medication is effective against a range of Gram-positive bacteria, including methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus faecium (VRE).

Key Benefits & Uses

• Treatment of complicated skin and skin structure infections (cSSSI) caused by susceptible bacteria.
• Treatment of community-acquired pneumonia (CAP) caused by susceptible bacteria.
• Treatment of ventilator-associated pneumonia (VAP) caused by susceptible bacteria.
• Treatment of uncomplicated skin and skin structure infections (uSSSI) caused by susceptible bacteria.

Active Ingredient & Action

Linezolid, the active ingredient in ЛІНОЗИД, works by inhibiting protein synthesis in bacteria. It binds to the 50S ribosomal subunit, preventing the formation of the 70S initiation complex and thereby inhibiting the translation of mRNA into protein. This action results in the death of bacterial cells, effectively treating infections caused by susceptible bacteria.

Important Notes

ЛІНОЗИД should only be used under the guidance of a healthcare professional. It is essential to follow the recommended dosage and duration of treatment to avoid the development of resistance and to minimize the risk of adverse effects. Patients taking ЛІНОЗИД should be monitored for signs of thrombocytopenia, as well as other potential side effects.